<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00952601</url>
  </required_header>
  <id_info>
    <org_study_id>AtkinsTourette</org_study_id>
    <nct_id>NCT00952601</nct_id>
  </id_info>
  <brief_title>Pilot Study of the Modified Atkins Diet for Tourette Syndrome</brief_title>
  <official_title>Pilot Study of the Modified Atkins Diet for Tourette Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johns Hopkins University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Johns Hopkins University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Pharmacotherapy has long been considered the primary approach for tic suppression in Tourette
      syndrome (TS). Unfortunately, medications are often ineffective and frequently have
      significant side-effects. This is a pilot therapeutic study using a dietary approach, the
      modified Atkins diet (MAD). The goal of this study is to establish the safety, tolerability,
      and efficacy of dietary therapy in patients with TS (&quot;proof of concept&quot;) and to determine
      whether this intervention is worthy of evaluation in large-scale clinical trials. The
      modified Atkins diet mimics the well established ketogenic diet, but in a less-restrictive
      dietary manner. Dietary approaches using the MAD/ketogenic diet are currently under
      investigation for neurological conditions other than epilepsy, including Alzheimer disease,
      headaches, autism, narcolepsy, brain tumors, traumatic brain injury, Parkinson's disease, and
      depression.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Insufficient interest and recruitment - study ended prematurely by investigators
  </why_stopped>
  <start_date>September 2008</start_date>
  <completion_date type="Actual">July 2010</completion_date>
  <primary_completion_date type="Actual">July 2010</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Tic frequency</measure>
    <time_frame>2 months</time_frame>
    <description>Number of tics per day, intensity, severity, will be compared to baseline (pre-diet)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Ketosis</measure>
    <time_frame>2 months</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Tourette Syndrome</condition>
  <arm_group>
    <arm_group_label>Modified Atkins Diet</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients are started on the modified Atkins diet at 15 grams per day.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Modified Atkins diet</intervention_name>
    <description>Low carbohydrate diet</description>
    <arm_group_label>Modified Atkins Diet</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Ages 12-65 years

          -  Tourette syndrome (vocal and motor tics for over a year)

          -  &gt; 20 score on the Yale Global Tic Severity Scale

          -  Ability to follow instructions and comply with the dietary changes

        Exclusion Criteria:

          -  Secondary tics

          -  Underweight (BMI &lt; 5%)

          -  Prior use of the Atkins diet for over 2 days

          -  High cholesterol or triglycerides

          -  Major depression or anxiety disorder

          -  Pregnancy

          -  Substance abuse
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Johns Hopkins Hospital</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21287</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Kossoff EH, Dorward JL. The modified Atkins diet. Epilepsia. 2008 Nov;49 Suppl 8:37-41. doi: 10.1111/j.1528-1167.2008.01831.x. Review.</citation>
    <PMID>19049584</PMID>
  </reference>
  <verification_date>July 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 3, 2009</study_first_submitted>
  <study_first_submitted_qc>August 4, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 6, 2009</study_first_posted>
  <last_update_submitted>July 14, 2010</last_update_submitted>
  <last_update_submitted_qc>July 14, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 15, 2010</last_update_posted>
  <responsible_party>
    <name_title>Eric Kossoff MD</name_title>
    <organization>Johns Hopkins University</organization>
  </responsible_party>
  <keyword>Tourette</keyword>
  <keyword>Atkins</keyword>
  <keyword>Ketosis</keyword>
  <keyword>Tic</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Tourette Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

